Associated Papers
An Extended Phenotype of PPP1R13L Cardiocutaneous Syndrome.
Coudert A et al.
American Journal of Medical Genetics. Part A, 2025
Variable phenotype of a null PPP1R13L allele in children with dilated cardiomyopathy.
Tulbah S et al.
American Journal of Medical Genetics. Part A, 2024
Exploring the complex spectrum of dominance and recessiveness in genetic cardiomyopathies.
Lipov A et al.
Nature Cardiovascular Research, 2023
38666070 (PubMed )
Supplement: 44161_2023_346_MOESM3_ESM.xlsx › S1
Novel homozygous stop-gain pathogenic variant of PPP1R13L gene leads to arrhythmogenic cardiomyopathy.
Kalayinia S et al.
Bmc Cardiovascular Disorders, 2022
Biallelic variants in PPP1R13L cause paediatric dilated cardiomyopathy.
Robinson HK et al.
Clinical Genetics, 2020
The Israeli national population program of genetic carrier screening for reproductive purposes. How should it be continued?
Zlotogora J
Israel Journal of Health Policy Research, 2019
31839005 (PubMed )
Supplement: 13584_2019_345_MOESM1_ESM.xlsx › Arabs_not_Negev_Bedouins_
Sequence variation in PPP1R13L results in a novel form of cardio-cutaneous syndrome.
Falik-Zaccai TC et al.
Embo Molecular Medicine, 2017
Select a paper to view details